FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3028016985> ?p ?o ?g. }

• W3028016985 endingPage "e218" @default.
• W3028016985 startingPage "e210" @default.
• W3028016985 abstract "Purpose Our purpose was to investigate time efficiency and target coverage for prostate stereotactic ablative radiation therapy (SABR) using triggered imaging (TI) and auto beam hold. Methods and Materials A total of 20 patients were treated with volumetric modulated arc–based SABR. Treatment verification consisted of pre- and post-radiation therapy cone beam computed tomography (CBCT) with gold marker-based TI every 3 seconds. In case of ≥3 mm (deviation limit) displacement, the treatment was interrupted and imaging-based correction was performed. Beam interruptions, intrafractional shifts, and treatment times were recorded. Prostate, rectum, and bladder were delineated on each CBCT. Target coverage was evaluated by comparing the individual prostate delineations with 98% isodose contour volumes (% of the evaluated volumes exceeding the reference). Both inter- and intrafractional changes of bladder and rectal volumes were assessed. Results The average overall treatment time (±standard deviation) was 18 ± 11 min, with a radiation delivery time of 6 ± 3 min if no intrafractional CBCT acquisitions were necessary (91% of fractions). On average, 1.2 beam interruptions per fraction were required with 0/1 correction in 71% of the fractions. The mean residual 3-dimensional shift was 1.6 mm, exceeding the deviation limit in 8%. In the case of intrafractional CBCT and/or ≥2 corrections the treatment time dramatically increased. The 98% isodose lines did not encompass the prostate in only 8/180 (4%) evaluations in 6 different patients, leading to a loss of D98 between 0.1%-6% as a worst case scenario. The bladder volumes showed significant increases during treatment (P < .01) while rectal volumes were stable. Conclusions Time efficiency of TI + auto beam hold with 3 mm/3 sec threshold during prostate SABR is comparable with competitive techniques, resulting in minimal 3-dimensional residual errors with maintained target coverage. Technical developments are necessary to further reduce radiation delivery time. Use of CBCT allowed full control of rectal volumes, while bladder volumes showed significant increases over time." @default.
• W3028016985 created "2020-05-29" @default.
• W3028016985 creator A5003928379 @default.
• W3028016985 creator A5004641035 @default.
• W3028016985 creator A5023684589 @default.
• W3028016985 creator A5031210678 @default.
• W3028016985 creator A5045164379 @default.
• W3028016985 creator A5062560223 @default.
• W3028016985 creator A5071116323 @default.
• W3028016985 creator A5084842598 @default.
• W3028016985 creator A5088187119 @default.
• W3028016985 creator A5091141208 @default.
• W3028016985 date "2021-03-01" @default.
• W3028016985 modified "2023-10-18" @default.
• W3028016985 title "Triggered Imaging With Auto Beam Hold and Pre-/Posttreatment CBCT During Prostate SABR: Analysis of Time Efficiency, Target Coverage, and Normal Volume Changes" @default.
• W3028016985 cites W2003173557 @default.
• W3028016985 cites W2019819653 @default.
• W3028016985 cites W2030378684 @default.
• W3028016985 cites W2089502905 @default.
• W3028016985 cites W2094442174 @default.
• W3028016985 cites W2103237521 @default.
• W3028016985 cites W2107927220 @default.
• W3028016985 cites W2112473204 @default.
• W3028016985 cites W2120269429 @default.
• W3028016985 cites W2298987870 @default.
• W3028016985 cites W2345333796 @default.
• W3028016985 cites W2394760474 @default.
• W3028016985 cites W2467790292 @default.
• W3028016985 cites W2591855782 @default.
• W3028016985 cites W2594113537 @default.
• W3028016985 cites W2611733921 @default.
• W3028016985 cites W2791394160 @default.
• W3028016985 cites W2791694382 @default.
• W3028016985 cites W2800324864 @default.
• W3028016985 cites W2911158923 @default.
• W3028016985 cites W2914880936 @default.
• W3028016985 cites W2918605096 @default.
• W3028016985 cites W2927781059 @default.
• W3028016985 cites W2945322497 @default.
• W3028016985 cites W2973514824 @default.
• W3028016985 doi "https://doi.org/10.1016/j.prro.2020.04.014" @default.
• W3028016985 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32454177" @default.
• W3028016985 hasPublicationYear "2021" @default.
• W3028016985 type Work @default.
• W3028016985 sameAs 3028016985 @default.
• W3028016985 citedByCount "5" @default.
• W3028016985 countsByYear W30280169852021 @default.
• W3028016985 countsByYear W30280169852022 @default.
• W3028016985 countsByYear W30280169852023 @default.
• W3028016985 crossrefType "journal-article" @default.
• W3028016985 hasAuthorship W3028016985A5003928379 @default.
• W3028016985 hasAuthorship W3028016985A5004641035 @default.
• W3028016985 hasAuthorship W3028016985A5023684589 @default.
• W3028016985 hasAuthorship W3028016985A5031210678 @default.
• W3028016985 hasAuthorship W3028016985A5045164379 @default.
• W3028016985 hasAuthorship W3028016985A5062560223 @default.
• W3028016985 hasAuthorship W3028016985A5071116323 @default.
• W3028016985 hasAuthorship W3028016985A5084842598 @default.
• W3028016985 hasAuthorship W3028016985A5088187119 @default.
• W3028016985 hasAuthorship W3028016985A5091141208 @default.
• W3028016985 hasConcept C105795698 @default.
• W3028016985 hasConcept C121608353 @default.
• W3028016985 hasConcept C126322002 @default.
• W3028016985 hasConcept C126838900 @default.
• W3028016985 hasConcept C149782125 @default.
• W3028016985 hasConcept C187625094 @default.
• W3028016985 hasConcept C19617505 @default.
• W3028016985 hasConcept C22679943 @default.
• W3028016985 hasConcept C2776235491 @default.
• W3028016985 hasConcept C2779813781 @default.
• W3028016985 hasConcept C2780192828 @default.
• W3028016985 hasConcept C2989005 @default.
• W3028016985 hasConcept C33923547 @default.
• W3028016985 hasConcept C509974204 @default.
• W3028016985 hasConcept C544519230 @default.
• W3028016985 hasConcept C71924100 @default.
• W3028016985 hasConcept C85393063 @default.
• W3028016985 hasConcept C91602232 @default.
• W3028016985 hasConceptScore W3028016985C105795698 @default.
• W3028016985 hasConceptScore W3028016985C121608353 @default.
• W3028016985 hasConceptScore W3028016985C126322002 @default.
• W3028016985 hasConceptScore W3028016985C126838900 @default.
• W3028016985 hasConceptScore W3028016985C149782125 @default.
• W3028016985 hasConceptScore W3028016985C187625094 @default.
• W3028016985 hasConceptScore W3028016985C19617505 @default.
• W3028016985 hasConceptScore W3028016985C22679943 @default.
• W3028016985 hasConceptScore W3028016985C2776235491 @default.
• W3028016985 hasConceptScore W3028016985C2779813781 @default.
• W3028016985 hasConceptScore W3028016985C2780192828 @default.
• W3028016985 hasConceptScore W3028016985C2989005 @default.
• W3028016985 hasConceptScore W3028016985C33923547 @default.
• W3028016985 hasConceptScore W3028016985C509974204 @default.
• W3028016985 hasConceptScore W3028016985C544519230 @default.
• W3028016985 hasConceptScore W3028016985C71924100 @default.
• W3028016985 hasConceptScore W3028016985C85393063 @default.
• W3028016985 hasConceptScore W3028016985C91602232 @default.
• W3028016985 hasIssue "2" @default.
• W3028016985 hasLocation W30280169851 @default.

• next